Regenxbio Other Cashflows From Financing Activities from 2010 to 2025

RGNX Stock  USD 8.57  0.41  5.02%   
Regenxbio Other Cashflows From Financing Activities yearly trend continues to be fairly stable with very little volatility. Other Cashflows From Financing Activities is likely to outpace its year average in 2025. During the period from 2010 to 2025, Regenxbio Other Cashflows From Financing Activities regression line of annual values had significance of  0.51 and arithmetic mean of  9,445,984. View All Fundamentals
 
Other Cashflows From Financing Activities  
First Reported
2014-09-30
Previous Quarter
-7.7 M
Current Value
-6.1 M
Quarterly Volatility
38.8 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 M, Interest Expense of 16.3 M or Selling General Administrative of 50.8 M, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 1.55. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Build AI portfolio with Regenxbio Stock
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Other Cashflows From Financing Activities Growth Pattern

Below is the plot of the Other Cashflows From Financing Activities of Regenxbio over the last few years. It is Regenxbio's Other Cashflows From Financing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Other Cashflows From Financing Activities10 Years Trend
Pretty Stable
   Other Cashflows From Financing Activities   
       Timeline  

Regenxbio Other Cashflows From Financing Activities Regression Statistics

Arithmetic Mean9,445,984
Coefficient Of Variation630.71
Mean Deviation34,760,381
Median1,965,000
Standard Deviation59,576,685
Sample Variance3549.4T
Range240.1M
R-Value(0.18)
Mean Square Error3682.7T
R-Squared0.03
Significance0.51
Slope(2,224,847)
Total Sum of Squares53240.7T

Regenxbio Other Cashflows From Financing Activities History

2025-37.6 M
2024-39.6 M
2023-41.7 M
2022-30.6 M
2021-23 M
2020198.4 M
20197.1 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Other Cashflows From Financing Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Cashflows From Financing Activities-39.6 M-37.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.